News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
167 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (25773)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (205)
2 (212)
3 (281)
4 (278)
5 (122)
6 (5)
7 (3)
8 (167)
9 (263)
10 (216)
11 (235)
12 (115)
13 (3)
14 (9)
15 (240)
16 (261)
17 (192)
18 (222)
19 (132)
20 (17)
21 (46)
22 (200)
23 (295)
24 (242)
25 (259)
26 (121)
27 (8)
28 (12)
29 (232)
30 (334)
31 (209)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Allergan Presents New Research at the American College of Gastroenterology Annual Scientific Meeting (ACG 2018)
American College of Gastroenterology Annual Scientific Meeting (ACG), from October 5-10, 2018 in Philadelphia, PA.
October 8, 2018
·
7 min read
BioMidwest
New Real-World Data Analyses Support the Long-Term Use of Entyvio® (vedolizumab) in Bio-Naïve Patients for the Treatment of Moderate to Severe Ulcerative Colitis or Crohn’s Disease
A total of 10 Entyvio abstracts were accepted for presentation at the meeting.
October 8, 2018
·
10 min read
Pharm Country
Salix to Present Clinical Data for XIFAXAN® (RIFAXIMIN) and PLENVU® at the American College of Gastroenterology Annual Meeting
Salix Pharmaceuticals (“Salix”), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases and a wholly owned subsidiary of Bausch Health Companies Inc.
October 8, 2018
·
11 min read
Immunovia Announces Strategic Focus Centered on IMMray™ Blood-based Biomarker Signatures for Rheumatoid Arthritis Within Autoimmunity
Encouraged by the promising discovery study results previously reported, Immunovia´s prime focus in autoimmunity testing will be to develop IMMray™ blood-based biomarker signatures for the management of rheumatoid arthritis.
October 8, 2018
·
6 min read
BioCapital
Research and Education’s Technical Community to Gather in Orlando for the 2018 Internet2 Technology Exchange
Meeting program includes 83 technical presentations, 78 working meetings, four advanced networking demonstrations, nine in-depth tutorials, and six co-located events
October 8, 2018
·
2 min read
Business
DexCom Schedules Third Quarter 2018 Earnings Release and Conference Call for November 6, 2018 at 4:30 p.m. Eastern Time.
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2018 financial results after market close on Tuesday, November 6, 2018.
October 8, 2018
·
1 min read
Drug Development
Exelixis Initiates Phase 3 Pivotal Trial (COSMIC-311) of Cabozantinib in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Who Have Progressed after Prior VEGFR-Targeted Therapy
Exelixis, Inc. (Nasdaq: EXEL) today announced the initiation of a phase 3 pivotal trial (COSMIC-311) of single-agent cabozantinib in patients with radioiodine-refractory differentiated thyroid cancer (DTC) who have progressed after up to two prior vascular endothelial growth factor receptor (VEGFR)-targeted therapies.
October 8, 2018
·
11 min read
Job Trends
GHX Says Collaboration Critical to Advance Clinically Integrated Supply Chains
Driving the next level of innovation in healthcare will require significant collaboration throughout the industry.
October 8, 2018
·
3 min read
Pharm Country
ForLikeMinds Launches First Online Peer-based Support Community Dedicated to Mental Illness
ForLikeMinds (www.forlikeminds.com) has launched the first online peer-based support community dedicated to mental illness, to coincide with Mental Illness Awareness Week.
October 8, 2018
·
2 min read
Business
Atlas Genetics Announces Company Rebranding, Changes Name To Binx Health
Company charts expanded direction and names new key additions
October 8, 2018
·
5 min read
Previous
11 of 17
Next